Blue Chip Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.11M Buy
7,440
+280
+4% +$41.4K 0.87% 30
2020
Q2
$1.01M Buy
7,160
+354
+5% +$51.6K 0.95% 30
2020
Q1
$893K Buy
6,806
+446
+7% +$63.3K 1.11% 25
2019
Q4
$928K Sell
6,360
-498
-7% -$67.5K 0.86% 32
2019
Q3
$887K Buy
6,858
+407
+6% +$53.6K 0.93% 33
2019
Q2
$899K Sell
6,451
-398
-6% -$55.1K 0.95% 33
2019
Q1
$957K Sell
6,849
-133
-2% -$17.8K 1.08% 30
2018
Q4
$901K Sell
6,982
-230
-3% -$32.1K 1.18% 28
2018
Q3
$996K Buy
7,212
+133
+2% +$17.7K 1% 32
2018
Q2
$859K Sell
7,079
-200
-3% -$25K 0.93% 32
2018
Q1
$933K Buy
+7,279
New +$984K 0.96% 31

Other funds holding JNJ

Blue Chip Wealth Management's JNJ Position: Q3 2020 in Review

Blue Chip Wealth Management increased its Johnson & Johnson (JNJ) stake by 3.9% in Q3 2020, buying an estimated $41.4K and bringing the position to 7,440 shares worth $1.11M. The position accounts for 0.87% of the portfolio, ranked #30.

Blue Chip Wealth Management first reported a position in JNJ in Q1 2018 and has held it in 11 quarters since. 2,985 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Blue Chip Wealth Management held 7,440 shares of Johnson & Johnson worth $1.11M as of Q3 2020.
  • Blue Chip Wealth Management bought 280 Johnson & Johnson shares in Q3 2020, an estimated $41.4K.
  • Johnson & Johnson made up 0.87% of Blue Chip Wealth Management's portfolio in Q3 2020, its #30 holding.
  • Blue Chip Wealth Management first reported a position in Johnson & Johnson in Q1 2018 and has held it in 11 quarters since.
  • 2,985 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Blue Chip Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.